The diabetic foot management - Recent advance

International Journal of Surgery

Volumn 15, Issue , 2015, Pages 27-30

  Sinwar, Prabhu Dayal ^a  

^a S P MEDICAL COLLEGE   (India)

Author keywords

Amputation; Angioplasty; Atherosclerosis; Diabetic foot; Neuropathic ulcer; Neuropathy

Indexed keywords

CITALOPRAM; DULOXETINE; GABAPENTIN; IMIPRAMINE; NORADRENALIN; PAROXETINE; SEROTONIN ANTAGONIST;

ARTERIAL STIFFNESS; ARTERY RECONSTRUCTION; BIOMECHANICS; BLOOD VESSEL CALCIFICATION; BONE DISEASE; CLINICAL FEATURE; DIABETIC ANGIOPATHY; DIABETIC FOOT; DIABETIC NEUROPATHY; DIABETIC PATIENT; DOPPLER FLOWMETRY; FOOT; HUMAN; INFECTION; INFECTION CONTROL; INFLAMMATION; INJURY; ISCHEMIA; LUMBAR SYMPATHECTOMY; MICROANGIOPATHY; MICROSCOPY; NEUROPATHIC PAIN; OXIMETRY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL NEUROPATHY; PLETHYSMOGRAPHY; PRIORITY JOURNAL; REVIEW; SUGAR INTAKE; WEIGHT BEARING; WEIGHT REDUCTION; WOUND DRESSING; AMPUTATION; PATHOLOGY;

AMPUTATION; DIABETIC FOOT; HUMANS;

EID: 84923883592     PISSN: 17439191     EISSN: 17439159     Source Type: Journal    
DOI: 10.1016/j.ijsu.2015.01.023     Document Type: Review

References (35)

1. Boulton A.J.M. The pathway to ulceration: aetiopathogenesis. The Foot in Diabetes 2000, 19-31. John Wiley & Sons Ltd, Chichester. third ed. A.J.M. Boulton, H. Connor, P.R. Cavanagh (Eds.).
2. Reiber G.E., Vileikyte L., Boyko E.J., et al. Causal pathway for incident lower extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999, 22:157-162.
3. Williams D.R.R. Hospital admissions of diabetic patients: information from hospital activity analysis. Diabet. Med. 1985, 2:27-32.
4. Lavery L.A., Ashry H.R., van Houtum W., Pugh J.A., Harkless L.B., Basu S. Variation in the incidence and proportion of diabetes-related amputations in minorities. Diabetes Care 1996, 19:48-52.
5. Lavery L.A., van Houtum W.H., Ashry H.R., Armstrong D.G., Pugh J.A. Diabetes-related lower-extremity amputations disproportionately affect Blacks and Mexican Americans. South Med. J. 1999, 92:593-599.
6. Reiber G.E., Boyko E.J., Smith D.G. Lower extremity foot ulcers and amputations in diabetes. Diabetes in America 1995, vol. 95:409-428. NIH Publication. second ed.
7. Lavery L.A., Armstrong D.G., Wunderlich R.P., Mohler M.J., Wendel C.S., Lipsky B.A. Risk factors for foot infections in individuals with diabetes. Diabetes Care 2006, 29. 1288_93.
8. Edmonds M.E. The diabetic foot: pathophysiology and treatment. Clinics in Endocrinology and Metabolism 1986, P880-P916. W.B. Saunders, London. P.J. Watkins (Ed.).
9. Boulton A.J.M., Ward J.D. Diabetic neuropathies and pain. Clinics in Endocrinology and Metabolism 1986, vol. 15:4. W.B. Saunders, London.
10. Dyck P.J., Kratz K.M., Karnes J.L., et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993, 43:817-824.
11. Boulton A.J.M., Malik R.A., Arezzo J.C., Sosenko J.M. Diabetic somatic neuropathies: technical review. Diabetes Care 2004, 27:1458-1486.
12. Edmonds M.E. The neuropathic foot in diabetics, part-1: blood flow. Diabet. Med. 1986, 3:111-115.
13. Sinha S., Munichoodappa C.S., Kozak G.P. Neuroarthropathy (Charcot's joints) in diabetes mellitus. Med. Baltim. 1972, 52:191-210.
14. Ward J.D., Simms J.M., Knight G., et al. Venous distension in the diabetic neuropathic foot (physical sign of arteriovenous shunting). J.Roy. Soc. Med. 1983, 76:1011-1014.
15. Joseph W.S., LeFrock J.L. The pathogenesis of diabetic foot infections immunopathy, angiopathy, and neuropathy. J.Foot Surg. 1987, 26. S7_11.
16. Parving H.H., Rasmussem S.M. Transcapillary escape rate of albumin and plasma volume in short and long term juvenile diabetics. J.Clin. Lab. Invest. 1973, 32:81-87.
17. Wagner F.W. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle 1981, 2. 64_122.
18. Oyibo S.O., Jude E.B., Tarawneh I., Nguyen H.C., Harkless L.B., Boulton A.J. Acomparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification systems. Diabetes Care 2001, 24. 84_8.
19. Jamal G.A., Hansen S., Weir A.I., Ballantyne J.P. An improved automated method for the measurement of thermal threshold. 1. Normal subjects. J.Neurol. Neurosurg. Psychiatr. 1985, 48:354-360.
20. Jamal G.A., Weir A.I., Hansen S., Ballantyne J.P. An improved automated method for the measurement of thermal threshold. 2. Patients with peripheral neuropathy. J.Neurol. Neurosurg. Psychiatr. 1985, 48:361-366.
21. Fruhstorfur H., Lindbloom V., Schmidt W.G. Method for quantitative estimation of thermal thresholds in patients. J.Neurol. Neurosurg. Psychiatr. 1976, 39:1071-1075.
22. Hurley J.J., Hershey F.B., Auer A.I., Binningtoni H.B. Noninvasive evaluation of peripheral arterial status-the physiologic approach. The Diabetic Foot 1983, 120. C.V. Mosby Company, London. M.E. Levin, L.W. Oneal (Eds.).
23. Delbridge L., Ctercteko G., Fowler C., Reeve T.S., Le Quesne L.P. The aetiology of diabetic neuropathic foot ulceration. Br. J. Surg. 1985, 72:1-6.
24. Boulton A.J.M., Franks C.I., Betts R.P., Duckworth T., Ward J.D. Reduction of abnormal foot pressures in diabetic neuropathy using a new polymer insole material. Diabetes Care 1984, 7:42-46.
25. Patton J., Bruce G., Jones R., Stenhouse E. Effectiveness of insoles used for the prevention of ulceration in the neuropathic diabetic foot: a systematic review. J.Diabetes Complicat. 2011, 25:52-62.
26. Lavery L.A., Vela S.A., Fleischli J.G., Armstrong D.G., Lavery D.C. Reducing plantar pressure in the neuropathic foot. A comparison of footwear. Diabetes Care 1997, 20:1706-1710.
27. Mueller M.J., Strube M.J., Allen B.T. Therapeutic footwear can reduce plantar pressures in patients with diabetes and transmetatarsal amputation. Diabetes Care 1997, 20:637-641.
28. Reiber G.E., Smith D.G., Boone D.A., et al. Design and pilot testing of the DVA/Seattle Footwear System for diabetic patients with foot insensitivity. J.Rehabil. Res. Dev. 1997, 34(1):1-8.
29. Tovey F.I. Establishing a diabetic shoe service. Pract. Diabetes 1985, 2:5-8.
30. Sindrup S.H., Gram L.F., Brosen K., Eshoj O., Mogensen B.I. The SSRI paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 1990, 42:135-144.
31. Max M.B., Lynch S.A., Muir J., et al. Effects of desipramine, amitriptyline and fluoxetine on pain relief in diabetics in diabetic neuropathy. N.Engl. J. Med. 1992, 326:1250-1256.
32. Sindrup S.H., Bjerre U., Dejgaard A., et al. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin. Pharmacol. Ther. 1992, 53:547-552.
33. McQuay H., Carrell D., Jadad A.R., Wilfen P., Moore A. Anticonvulsant drugs for the management of pain: a systematic review. BMJ 1995, 311:1047-1052.
34. Jensen T.S. Anticonvulsants in neuropathic pain: rationale and clinical evidence. Eur. J. Pain 2002, 6(Suppl.A):61-68.
35. Epstein H.H. The management of adult diabetes. Can. Fam. Physician 1973 Oct, 19(10):69-72.